Perrigo and Cobrek Pharmaceuticals received regulatory approval for the 0.12% formulation of betamethasone validate foam to address scalp psoriasis. Betamethasone is the generic version of Stiefel Labs' Luxiq foam.
Perrigo, Cobrek gets FDA nod for generic Luxiq foam
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||